Immerse yourself in the electrifying world of Mortal Kombat Project 4.1+ with this thrilling playthrough featuring the fierce fighter, Li Mei. Watch as we dive into intense battles, showcasing Li ...

EOG Resources' (NYSE:EOG) joint shale project with Abu Dhabi National Oil Company is progressing on schedule, with ADNOC drilling horizontal wells and oil successfully tested to the surface in the ...

As a general rule, any first-person game where you’re walking around derelict areas and pointing a camera at things is probably going to be super creepy, and upcoming asymmetrical shooter Project ...

DENVER, Aug. 18, 2025 /PRNewswire/ -- All Colorado kids deserve a chance to play sports – and the Daniels Fund and Project Play Colorado are making it possible. In collaboration with hundreds of youth ...

For more than 10 years Tyler has used his experience in smart home tech to craft how-to guides, explainers, and recommendations for technology of all kinds. From using his home in beautiful Bend, OR ...

Noah Centineo will reportedly be starring in John Rambo, a prequel to Sylvester Stallone’s iconic 1982 action film First Blood. Centineo recently earned praise for his star turn in Black Adam. However ...

BEND, Ore. (KTVZ) - A new sign at Riverbend Park is asking river users to choose “river-friendly” sun protection. It’s part of Girl Scout Serafina Quercini’s Gold Award project, aimed at reducing ...

President Donald Trump has been threatening tariffs on pharmaceuticals for months. This week, he told CNBC that he’s planning to impose a “small tariff” on prescription drugs soon and then raise that ...

After spending 16 years lying dormant at the bottom of a lake due to complicated rights issues relating to the character, Jason Voorhees is finally set to return to terrorize a new group of teenage ...

Khaleda Rahman is Newsweek's National Correspondent based in London, UK. Her focus is reporting on education and national news. Khaleda joined Newsweek in 2019 and had previously worked at the ...

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications. The market for drugs that treat obesity and help people lose weight is soaring.